Patent ID: 6262017
Filing Date: 2001-07-17
Classification: A61K,A61L,A61P,C07K,C12N

Abstract:
A compound of formulaAa.sup.1 -aa.sup.2 -aa.sup.3 -aa.sup.4 -(Gly).sub.n --OHwherein:Aa.sup.1 represents the residue of an amino acid selected from the group consisting of H-Lys, H-Arg, H-Orn and 6-aminocaproic acid (Acp);aa.sup.2, and aa.sup.4 independently represent the residue of an amino acid selected from the group consisting of lysine (Lys), arginine (Arg), and ornithine (Orn);aa.sup.3 represents the residue of an amino acid selected from the group consisting of alanine (Ala), glycine (Gly), valine (Val), leucine (Leu), isoleucine (Ile), serine (Ser), threonine (Thr), cysteine (Cys), methionine (Met), asparagine (Asn), norleucine (Nle), norvaline (Nva), and 2-aminobutyric acid (Abu); andn is an integer from 1 to 6;or pharmaceutically acceptable salt thereof.